NIST-traceable fast quantitative SPECT/CT imaging of Lu-177: Personalized radiopharmaceutical therapy with Symbia Pro.specta | Symposium at SNMMI 2024
06/11/2024
Michael Morris, MD, MS, co-founder physician, United Theranostics, Glen Burnie, Maryland, USA
United Theranostics discusses how it leverages fast 177Lu scans, workflow automation, and precise quantification to deliver more efficient, patient-centered radiopharmaceutical therapy.
